Research graph
References from Plasma cortisol cut-off concentrations using the dexamethasone suppression test in patients with adrenal incidentalomas. Local targets link to admitted publications; unresolved targets remain external evidence.
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
10.1093/ejendo/lvad066 · 2023 · External reference
Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis
10.1093/ejendo/lvad134 · 2023 · External reference
Lowering the dexamethasone suppression test cut-off: is it time yet
10.1007/s40618-025-02679-1 · 2025 · External reference
Mortality not increased in patients with nonfunctional adrenal adenomas: a matched cohort study
10.1210/clinem/dgad074 · 2023 · External reference
Usefulness of cortisol/ACTH ratio (CAR) for diagnosis of Cushing’s syndrome: comparison of CAR with findings in dexamethasone suppression test
10.1038/s41598-022-22676-1 · 2022 · External reference
Interpretation of abnormal dexamethasone suppression test is enhanced with use of synchronous free cortisol assessment
10.1210/clinem/dgab724 · 2022 · External reference
Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation
10.1007/s40618-020-01197-6 · 2020 · External reference
Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test
10.1530/eje-17-0078 · 2017 · External reference
Value of the serum dexamethasone determination for the diagnosis of mild autonomous cortisol secretion
10.1111/cen.70065 · 2026 · External reference
Serum cortisol assay performance following the 1 mg overnight dexamethasone suppression test
10.1177/00045632231179560 · 2023 · External reference
Dynamic testing of cortisol in consecutive patients with suspected adrenal disorders: a comparison of Elecsys Cortisol II and LC-MS/MS
10.1530/ec-25-0600 · 2026 · External reference
Impact of old and current immunoassays on the 1 mg overnight dexamethasone suppression test: comparison with LC-MS/MS
10.1093/ejendo/lvaf141 · 2025 · External reference
Unresolved reference
External reference
STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies
10.1136/bmj.h5527 · 2015 · External reference
Endogenous subclinical hypercortisolism: diagnostic uncertanties and clinical implications
10.1007/bf03344133 · 2006 · External reference
Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas
10.1530/ec-20-0419 · 2020 · External reference
Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome-recommendations for a protocol for biochemistry laboratories
10.1177/000456329703400302 · 1997 · External reference
Is subclinical Cushing’s syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined
10.1126/science.133.3464.1643 · 2010 · External reference
Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas
10.7326/m20-7946 · 2021 · External reference
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study
10.1016/s2213-8587(22)00100-0 · 2022 · External reference
Cardiometabolic disease burden and steroid excretion in benign adrenal tumors a cross-sectional multicenter study
10.7326/m21-1737 · 2022 · External reference
Mortality in patients with nonfunctional adrenal tumors
10.1001/jamainternmed.2023.2442 · 2023 · External reference
Mild autonomous cortisol secretion: pathophysilogy, comorbidities and management approaches
10.1038/s41574-024-00984-y · 2024 · External reference
Suppressed ACTH is frequently unrelated to autonomous cortisol secretion in patients with adrenal incidentalomas
10.1210/jc.2010-0633 · 2019 · External reference
ACTH following overnight dexamethasone suppression can be used in the verification of autonomous cortisol secretion in patients with adrenal incidentalomas
10.1111/cen.14357 · 2021 · External reference
The role of cortisol/ACTH ratio for screening of subclinical hypercortisolism in patients with adrenal incidentalomas
10.1055/s-0043-101236 · 2018 · External reference
The reflex dexamethasone suppression test: development and assessment of reflexed serum dexamethasone measurement for the diagnosis of Cushing syndrome
10.1016/j.aed.2025.07.008 · 2025 · External reference
Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study
10.1210/jc.2001-011843 · 2002 · External reference
Cushing’s syndrome: a review of diagnostic tests
10.1016/0026-0495(79)90097-0 · 1979 · External reference
Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals
10.1210/jcem.83.1.4498 · 1998 · External reference
Visceral fat accumulation and postdexamethasone serum cortisol levels in patients with adrenal incidentaloma
10.1210/jc.2012-4276 · 2013 · External reference
Autonomous cortisol secretion in adrenal incidentalomas and increased visceral fat accumulation during follow-up
10.1111/cen.13408 · 2017 · External reference
The overnight dexamethasone test is a worthwhile screening procedure
10.1111/j.1365-2265.1990.tb00462.x · 1990 · External reference
Serum cortisol level after low dose dexamethasone suppression test may be predictive for diabetes mellitus and hypertension presence in obese patients: a retrospective study
10.1016/j.diabres.2020.108081 · 2020 · External reference
In obesity, HPA axis activity does not increase with BMI, but declines with aging: a meta-analysis of clinical studies
10.1371/journal.pone.0166842 · 2016 · External reference
Prediction of cortisol response to dexamethasone from age and basal cortisol in normal volunteers: a negative study
10.1007/bf00181258 · 1986 · External reference
Relationship between overnight dexamethasone suppression test and aging
10.7759/cureus.48383 · 2023 · External reference
Influence of age and relative weight on cortisol suppression in normal subjects
10.1176/ajp.144.5.646 · 1987 · External reference
Dexamethasone suppression in dementia, depression, and normal aging
10.1176/ajp.143.4.452 · 1986 · External reference
Serum cortisol: an up-to-date assessment of routine assay performance
10.1373/clinchem.2016.255034 · 2016 · External reference
Multicenter performance evaluation of a second generation cortisol assay
10.1515/cclm-2016-0400 · 2017 · External reference
Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience
10.1007/s42000-020-00185-y · 2020 · External reference
Reference intervals
10.1097/01.pat.0000426779.67065.7c · 2008 · External reference
Number of comorbidities predicts adrenal incidentaloma and autonomic cortisol secretion in obese individuals: a two-center cohort study
10.1007/s12020-025-04355-z · 2025 · External reference
